MML Investors Services LLC boosted its position in shares of Core Laboratories (NYSE:CLB) by 21.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,505 shares of the oil and gas company’s stock after acquiring an additional 986 shares during the period. MML Investors Services LLC’s holdings in Core Laboratories were worth $603,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Robeco Institutional Asset Management B.V. increased its stake in Core Laboratories by 60.7% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 1,096 shares of the oil and gas company’s stock valued at $120,000 after acquiring an additional 414 shares during the period. The Manufacturers Life Insurance Company boosted its holdings in Core Laboratories by 63.7% during the second quarter. The Manufacturers Life Insurance Company now owns 1,128 shares of the oil and gas company’s stock valued at $114,000 after purchasing an additional 439 shares in the last quarter. Suntrust Banks Inc. boosted its holdings in Core Laboratories by 19.8% during the fourth quarter. Suntrust Banks Inc. now owns 2,942 shares of the oil and gas company’s stock valued at $320,000 after purchasing an additional 486 shares in the last quarter. Swiss National Bank boosted its holdings in Core Laboratories by 0.3% during the third quarter. Swiss National Bank now owns 161,300 shares of the oil and gas company’s stock valued at $15,920,000 after purchasing an additional 500 shares in the last quarter. Finally, Forte Capital LLC ADV boosted its holdings in Core Laboratories by 4.6% during the fourth quarter. Forte Capital LLC ADV now owns 12,886 shares of the oil and gas company’s stock valued at $1,411,000 after purchasing an additional 570 shares in the last quarter.
A number of research firms have weighed in on CLB. TheStreet raised Core Laboratories from a “c” rating to a “b-” rating in a report on Thursday, February 1st. Zacks Investment Research raised Core Laboratories from a “hold” rating to a “buy” rating and set a $120.00 price objective on the stock in a report on Wednesday. ABN Amro downgraded Core Laboratories from a “buy” rating to a “hold” rating in a report on Tuesday, January 9th. Royal Bank of Canada set a $125.00 price objective on Core Laboratories and gave the company a “buy” rating in a report on Tuesday, January 30th. Finally, Deutsche Bank downgraded Core Laboratories from a “buy” rating to a “hold” rating and decreased their price objective for the company from $116.30 to $109.00 in a report on Thursday, January 11th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and five have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $112.18.
Shares of CLB traded down $3.42 on Friday, hitting $106.16. The company’s stock had a trading volume of 631,868 shares, compared to its average volume of 377,659. The company has a market capitalization of $4,688.45, a P/E ratio of 53.08 and a beta of 1.41. The company has a debt-to-equity ratio of 1.53, a current ratio of 1.98 and a quick ratio of 1.66. Core Laboratories has a fifty-two week low of $86.55 and a fifty-two week high of $121.39.
Core Laboratories (NYSE:CLB) last announced its earnings results on Wednesday, January 31st. The oil and gas company reported $0.58 EPS for the quarter, hitting the consensus estimate of $0.58. The business had revenue of $172.00 million for the quarter, compared to the consensus estimate of $171.92 million. Core Laboratories had a return on equity of 58.25% and a net margin of 12.60%. Core Laboratories’s revenue was up 15.1% compared to the same quarter last year. During the same period in the previous year, the business earned $0.41 EPS. sell-side analysts anticipate that Core Laboratories will post 2.7 EPS for the current fiscal year.
TRADEMARK VIOLATION NOTICE: “MML Investors Services LLC Boosts Holdings in Core Laboratories (CLB)” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this article on another publication, it was illegally copied and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://www.dispatchtribunal.com/2018/04/08/core-laboratories-clb-shares-bought-by-mml-investors-services-llc.html.
Core Laboratories Company Profile
Core Laboratories N.V. provides reservoir description, and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment comprises the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs.
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.